Healthcare -
Biotechnology - NASDAQ - US
$ 8.19
3.15 %
$ 308 M
Market Cap
4.88
P/E
TRDA - NET INCOME
Net Income TRDA - Entrada Therapeutics, Inc.
65.6 M
LAST VALUE
64.12%
2 YEAR CAGR
71.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR